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IN the first paper ofthis series (Salaman andRoe, 1953) it was shown that after
the apphcation ofethyl carbamate (urethane) to mouse skin, repeated treatment
with croton oil promoted the development of tumours. Urethane, when apphed
repeatedly alone, or after a single dose of 9: 10-dimethyl-1 : 2- benzanthracene
(DMBA), did not give rise to tumours. It was concluded that urethane was an
initiator ofcarcinogenesis, but not a carcinogen, or co-carcinogen, for mouse skin.
In the same paper attention was drawn to the fact that theinitiating doses of
-urethane used (120-360 mg.) were very large relative to an initiating dose of
DMBA ofcomparableefficiency (0-3 mg.). It waspointed out that in view ofthe
high solubility and rapid ehmination of urethane (Skipper et al. 1948, 1951;
Boyland and Rhoden, 1949), this discrepancy was not surprising ; and that, in
any case, no attempt had been made to determ'me the optimal dose of urethane,
which might prove to be smaller than those used.
The first of the two experiments described in the present paper was designed
to show the effects on theinitiating power ofurethane ofaltering (i) the totaldose,
.ii) thespacing ofappEcations, and (iii) thesolvent.
Berenblum and Shubik (1947, 1949b) sbowed that varying the interval bet-
ween an intiating dose of DMBA and a subsequent course of croton oil from 3 to
43 weeks, did not alter significantly the proportion of mice which developed
tumours. They concluded that the initiating effect of DMBA persisted without
change for at least 43 weeks.
In the second experiment described below we have studied the persistence of
the initiating effect of urethan'e in mouse skin.
MATERIALS AND METHODS.
Mice.-The mice used were stock albinos of the
" S
" strain (Salaman and
Gwynn, 1951) fed on cubes prepared according to the Rowett Institute formula
,(Thomson, 1930a, 1930b),plus fresh greenstufftwice a week, and water ad libitum.
Mice were vaccinated on.the tail with sheep lymph (kindly supphed by the
Lister Institute ofPreventiveMedicine) as aprecautionagainst ectromelia. Only
positive reactors were used.
All mice were aged 7-8 weeks at thebeginning ofexperiments.
Chemical agent&-Ethyl carbamate (urethane) and acetone (analar grade)
were obtained from BritishDrugHouses, polyethyleneglycol ofaverage molecular
weight 300 (carbowax 300) from the General Metallurgical and Chemical Co. Ltd.,TUMOUR-INITIATING EFFECT OF URETHANE 667
and croton oil from Messrs. Boots Pure Drug Co.,retailing theproduct ofMessrs.
Stafford Allen and Sons Ltd., 20 WharfRoad, N. 1.
Technique of applications.-The hair was chpped from the whole back, from
forelimbs to tail, before treatment and at intervals when necessary. Solutions in
acetone were delivered from calibratedpipettes, carebeing taken thattheyspread
asevenly aspossible over the wholeclipped area. Solutions in carbowax 300 were
delivered in the same way, andspread over the clipped area with aglassspreader.
EXPERIMENTAL.
First Experiment.
Relation between dose and initiating effect of urethane.
Forty male and 40 female mice were divided into 4 groups, each of 10 males.
and IO females. These groups were numbered 3, 4, 5, and 6, and were treated
with 180, 50, 10, and 2 mg. urethane in acetone respectively, apphed to the
clipped areas of skin. Subsequently, after an interval of three weeks, all groups
received a standard course of 18 weekly appHcations of 0-5 per cent croton oil in
acetone to the same areas. Details of these treatments are given in Table 1.
Each week, during the period of secondary treatment with croton oil, the mice
were examined for skin tumours, and those of I mm. diameter or more were
recorded.
Table I includes, besides Groups 3 to 6 described above, Group 1 (20 male
mice) which received croton oil apphcations only, and Group 2 (26 male mice)
which received 240 mg. urethane followedby a similar course ofcroton oil. These
two groups formed part of a previous experiment (Salaman and Roe, 1953).
The Table shows the incidence oftumour-bearing mice, and the total number of
tumours, in mice surviving until one week after the end of secondary treatment.
Fig. I shows the rates ofdevelopment of tumours in Groups 1 to 5. In Group 6,
which received only 2 mg. urethane as primary treatment, no more tumours ap-
peared than in the croton oil controls.
In these, as in other similarexperiments, small differences in tumour incidence
occurred between the sexes in individual groups, but were not regarded as signi- ficant. It wasthoughtjustifiable toignore the subdivision into sexes inGroups 3,
4) 5, and 6, inrecording the present results.
In Fig. 2 the average tumours per mouse surviving until one week after the
end of the secondary treatment is plotted against the total dose of urethane.
These points lie fairly close to a straight line which passes through a point at zero
dosage of urethane representing the average tumour incidence in mice receiving
croton oil only. It would seem that the relation between urethane dosage and
initiating effect does not differ significantly from simple direct proportionahty; and it is therefore unlikely that any dose of urethane less than 240 mg. will prove
to be either absolutely or relatively more effective. However, doses of urethane
intermediatebetween 50and 180mg. mustbetestedbefore adefinite conclusion can
be drawn on thispoint.
Effect of altering the spacing of applications on the initiating activity of 180 mg.
urethane.
Group 7: Twenty male mice were given 3 applications of 60 mg. urethane in
acetone at intervals of 4days. Three weeks after the first application ofurethane668 F. J. C. ROE AND M. H. SALAMAN
secondary treatment with croton oil was begun. Details of the primary and
secondary treatments, and results, are given in Table. 1. Conditions in Group 7
were identical with those inGroup 3, except that the interval betweenapplications
ofuretbane in Group 3 was 2 hours and in Group 7 was 4days.
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FIG. l.-Initiating power of urethane : relation between total dose and tumou-r development.
Abscissa = Time in weeks from beginning of croton oil applications. Ordinate = Average
number of tumours per surviving mouse.
0 ___M Group 1 : No urethane (croton oil control).
Group 2: 240 mg. urethane (given as 2 applications of 60 mg. in acetone
with an interval of 15 minutes, on Ist and 8th days).
0-------0 Group 3: 180 mg. urethane (given as 3 applications of 60 mg. in acetone
at intervals of 2 hours).
x -------- x Group 4: 50 mg. urethane (given as a single application in acetone).
0 Group 5 : IO mg. urethane (given as a single application in acetone).
All groups received 18 weekly applications of 0-3 ml. 0-5 per cent croton oil in acetone,
beginning 3 weeks (Groups 3, 4, and 5) or 4 weeks (Group 2) after the first application of
urethane. At the beginning of the experiinent there were 20 mice in Groups 1, 3, 4, and 5,
and 26 mice in Group 2. Numbers of survivors at the end of secondary treatment are
sbown in brackets.
The minor differences between these two groups in incidence of tumour-
bearing mice and in number oftumours, shown in Table 1, and in rate of tumour
development shown in Fig. 3, are not significant. It is concluded that this alter-
ation ofspacing of urethane apphcations did not affect initiating power.669 TUMOUR-INITIATING EFFECT OF URETHANE
Effect Of 8olvent on the rate of ab8orption and initiating action : a compariWn Of
acetone and carbowax 300.
It was expected that wider spacing of apphcations of urethane might have
increased the initiating effect of a given total dose, by avoiding overlapping of
periods of absorption and thus increasing the total duration of effective contact
with the skin. Another possible method ofachieving this end was tried, name)y
the use of a non-volatile solvent.
From previous experience it was known that after application of urethane
dissolved in acetone to the cHpped dorsal skin absorption is rapid, as shown by
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FiG. 2.-Initiating power of urethane: relation between total dose and tumour incidence
at end of secondary treatment. Abscissa = Total dose of urethane in milligrammes.
Ordinate = Average number of tumours per surviving mouse one week after 18th appli-
cation of croton oil. Treatment of the various groups is described in detafl in Table 1.
The points are experimental, the straight line is arbitrary.
theearly onset ofnarcosis. Threeappheations of 60 mg. urethane, at intervals of
15 minutes to 2 hours, is enough to produce an effect, varying from sluggishness
to deep coma, in the majority ofyoung mice.
In a preliminary experiment we used the rate of onset and maximum depth
of narcosis as a measure of the rate ofabsorption of urethane through the skin.
Ten female mice received appEcations of 20 per cent w/v urethane in acetone
at '-hourly intervals. A further 10 female mice received appheations of 20 per
cent w/v urethane in carbowax 300 at 1-hourly intervals. This solution was
viscous, and had to be spread with a glass rod.
Eight of the ten mice receiving the acetone solution showed moderate to deep
narcosis within 30 minutes of the third application ofurethane, whereas none of
those rece'
' the carbowax 300 solution showed more than sluggishness even
after 7 applications.
It was concluded that urethane was more slowly absorbed from carbowax 300
than from acetone and, therefore, that carbowax 300 was a suitable solvent for
the purpose ofprolonging contact between urethane and the skin.670 F. J. C. ROE AND M. H. SALAMAN
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Group 8: Twenty male mice were given 3 applications of 60 mg. urethane
dissolved in carbowax 300. Intervals of 4 days were left between these appli-'
cations, as inGroup 7. Details ofsubsequent treatment aregiven in Table 1.
The incidence of tumour-bearing mice, and the total number of tumours, in
mice surviving until one week after the end ofsecondary treatment are show-n in
Table L Fig. 3 shows the rate ofdevelopm'ent of tumours.
The results for Groups 7 and 8 are very similar. We conclude that the initia-
ting effect of 180 mg. urethane is not altered by substituting the viscous non-
volatile solvent carbowax 300 for acetone.
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FiG. 3.-The effects of changing (a) the solvent, and (b) the interval between applications,
on the initiating power of 180 n-ig. urethane on mouse skin. Abscissa = Time in weeks
from beginning of croton oil applications. Ordinate = Average number of tumours per surviving mouse.
m m Group 1 : No urethane (croton oil control). 0--------7 Group 3 : 3 applications of 60 mg. in acetone at intervals of 2 hours.
x -------- x Group 7 : 3 applications of 60 mg. in acetone at intervals of 4 days.
0 0 Group 8: 3 applications of 60 mg. in carbowax 300 at intervals of 4days.
All groups received 18 weekly applications of 0-3 ml. 0-5 per cent croton ofl in acetone,
beginning (in Groups 3, 7, and 8) three weeks after the first apphcation of urethane. At
thebeginning oftheexperiment there were 20 mice in each group. Numbers ofsurvivors at
the end ofsecondary treatment are shown in brackets.
Second Experiment.
Per8i8tence of the initiating effect of 240 mg. urethane in MOU8e 8kin.
GroUP8 2 and 9: Details of treatment are shown in Table IL Group 2 was
derived from a previouslyreported experiment and also appears in Table I of the
present paper. Both groups received 2applications of 60 mg. urethane on the Ist
46672 F. J. C. ROE AND M. H. SALAMAN
and 8th days of the experiment. In Group 2 (26 mice) the interval between
the last application of urethane and the firstweeklyapplicatio'n of croton oil was
3 weeks, whereas in Group 9 (24 mice) it was 24 weeks.
By the time mice ofGroup 9 were ready to begin croton oil treatment deaths
were beginning to occur from respiratory insufficiency, due to multiple lung
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FIG. 4.-Persistence of the initiating effect of 240 mg. urethane in mouse skin. Abscissa
Tiiine in weeks from beginning of croton oil appheations. Ordinate = Average number of
tumours per surviving mouse.
Group 2: 240 mg. urethane (0-3 ml. 20 per cent w/v in acetone applied
twice, with an interval of 15 minutes, on Ist and 8th days) foRowed,
after 3 -weeks from the final apphcation of urethane, by the first of 18
weekly applications of 0-3 ml. 0-5 per cent croton oil in acetone.
C)
--------0 Group 9: Treatment as in Group 2, except that the interval between
the finalapplication ofurethane and the first of croton ofl was 24 weeks.
Group 2 consisted initiaUy of 26 mice, and Group 9 of 24 mice. Numbers of survivors
are shown in brackets.
adenomas. Fifteen mice survived until thebeg' ofcroton oiltreatment, but
only I1 were alive at the end oftheexperiment ; moreover several ofthe survivors
were undersized compared with untreated mice of the same age and sex.
The rate oftumour.developmentduring croton oil treatment is shown inFig 4.
Undoubtedly the initiating effect of 240 mg. urethane persists in mouse skin for
at least 24 weeks. Taken asthey stand the figures show a reduction ofthe order673 TUMOUR-INITIATING EFFECT OF URETHANE
of 50 per cent in the effect ofurethane after this interval. But in view of the poor
state ofnutrition and low survival rate towards the end of croton oil treatment of
mice in Group 9 the significance of this difference is doubtful. A further uncer-
tainty is introduced by the difference in age at the time of tumour development.
It is possible that the promoting action of croton oil is less effective in old mice.
Per8i8tence of the initiating .ffect o 1-08 g. urethane in mOU8e 8kin.
GrOUP8 IO and II Details ofthe treatment are show-n in Table 11. Group II
also figured in a previous report (Group 13; Salaman and Roe, 1953). Both
groups received 18 weeklyapplications ofurethane, and 18 weekly applications of
croton oil, but while in Group 11 the treatments were alternated (a croton oil
application 4 days after each urethane application), in Group 10 croton oil treat-
ment began 3 weeks after the end of urethane treatment.
The survival rate in Group 10 was low, because of deaths from multiple lung
tumours, and from haemorrhagic hepatic tumours (unpublished results) and sur-
viving mice were underweight.
Fig. 5 shows the rate of development of tumours in the two groups, reckoned
from the beg'
i of croton oil treatment. Tumours appeared earher in Group
10. At thirteen weeks tumour incidence in the two groups was about equal.
Thereafter Group 11 went ahead, and at the end of the experiment showed a
tumourincidence almost double that ofGroup IO.
The early difference between the two groups is accounted for by the fact that
at that time Group IO had received the total dose ofurethane, whereasGroup II
had received only a part of it. The later difference suggests, as does the differ-
ence between Groups 2 and 9, a loss ofinitiating effect with the passage of time.
But here again the low survival rate and the poor state of nutrition of the older
mice prevent a firm conclusionbei.ag drawn.
DISC'LTSSION.
In the first paper of this series (Salaman and Roe, 1953) we showed that the
nitiating effect of 240 mg. urethane is approximately equal to that of 0-3 mg.
DMBA. It was suggested that a lower dose of urethane might prove to be rela-
tively, or even absolutely, more effective (cf. Shubik and Ritchie, 1953). The
results of the first experiment reported here virtuaRy exclude this possibility, for
the relation between dose andinitiating effect ofurethane approximates to simple
direct proportionality.
Altematively it was suggested that the apparent difference in potency might
be due to differences ofsolubiHty or rates ofabsorption. In this case aprolonga-
tion ofeffective contact ofthedrug with the-skin would beexpected to increase its
effect. In the second and third parts of the first experiment we attempted to
prolong the period of contact of urethane with the skin, firstly by increasing the
intervals between the three apphcations of urethane from 2 hours to 4 days
(Group 7), to prevent overlapping of the periods ofabsorption; and secondly by
combining this device with the use of a viscous non-volatile solvent-carbowax
300-(Group 8) which had been shown to delay absorption. Neither method
increased the initiating effect of 180 mg. urethane. These negative results,
though they do not decide the point definitely, make it unhkely that the relative
inefficiency ofurethane as an initiator is due to itsrapid passagethrough the skin.674 F. J. C. ROE AND M. H. SALAMAN
Thepossibility was considered that urethane can exert itsinitiating effectonly
onparticular cells, or on cells that have reached aparticular phase in the mitotic
cycle. Ifthis were so moresusceptible cells shouldhave beenexposed to urethane
inGroups 7 and 8, when urethane wasgiven at intervals of4days, than inGroup3,
when the intervals were only 2 hours. The fact that the yields of tumours were
equal in the three groups suggests either that there is no cyclic change in sus-
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FiG. 5.-Persistence of the initiating effect of 1-08 g. urethane in mouse skin. Abscissa
Tiirne in weeks from beginning of croton oil applications. Ordinate = Average number of
tumours per surviving mouse.
0 -------0 Group 10: Urethane foRowed by croton oil (18 weekly applications of
60 mg. urethane followed, after an interval of 3 weeks, by 18 weekly
applications of croton oil).
x x Group 11 : Urethane and croton oil given concurrently. (18 weekly
applications of 60 mg. urethane given on Tuesdays, and 18 weekly
applications of croton oil given on Fridays).
Both groups consisted initiaRy of 20 mice. Numbers of survivors are sliown in brackets.
ceptibility, or that a dose of 60 mg. urethane is smallcompared with that necessary
to act on aR'susceptible cells present.
Cramer and Stowell (1941), studying the effects of repeated apphcations of
20-methylcholanthrene to mouse skin, found that the carcinogenic effect of
monthlyappHeations wasgreater in relationtototal dosethan that ofweeklyappli-
cations. They concluded that when the interval between two apphcations of a
carcinogen is short the secondapplication diminishes thecarcinogenic effect of the
first byinhibiting cellularproliferatioin, as various carcinogens had been shown toTUMOUR-INITIATING EFFECT OF URETHANE 675
do (Haddow and Robinson, 1939). Urethane has also been shown to inhibit
cellular proliferation (Haddow and Sexton, 1946) and might be expected to
behave in the same way as 20-methylcholanthrene in this respect. But our
results in Groups 3, 8, and 9, showed that lengthening the interval between appli-
cations neither increased nor diminished theinitiating action of agiven total dose
of urethane (if we dismiss the unlikely possibility that enhancement was exactly
counteractedbyinhibition), and suggest that the effects ofindividualapplications
of urethane are additive, without mutual interference.
Berenblum and Shubik (1949a) treated mice withsingle applications ofDMBA
at various concentrations. All mice subsequently received a standard course of
croton oil treatment. It was found that the number of tumours produced was
approximately proportional to the concentration of DMBA applied. Shubik and
Ritchie (1953) carried out a somewhat similar experiment in which 3 groups of
mice were given 1, 2, and 3 applications respectively (with intervals of a week in
the latter groups) of DMBA at a constant concentration. Allgroupssubsequently
received a standard course of croton oil treatment. It was found that the
number of tumours produced was inversely related to the number ofappheations
of DMBA originally apphed. The results of these two experiments are, at first
sight, conflicting. Toexplain thisdiscrepancy Shubik and Ritchie (1953) suggest
that the carcinogen may have an inhibitory as well as an initiating effect, as did
Cramer and Stowell (1941), or else that a refractory period may follow each
application.
As stated above, one application of urethane does not inhibit the action of
another, nor is there evidence of a refractory period. Urethane produces no
detectable histological effect on the skin (Salaman and Roe, 1953), whereas
DMBA, like other carcinogenic hydrocarbons, produces a characteristic hyper-
plasia, (Pulhnger, 1940). This difference may account for the fact that repeated
apphcations of DMBA interfere with one another while those of urethane do not.
Berenblum and Shubik (1947, 1949b), studying the persistence ofthe initiat'mg effect of DMBA in mouse skin, concluded that there was almost 100 per cent
persistence for aperiod ofat least 43 weeks. They used as their criterion the per-
centage of mice developing tumours in each group. We have used, inthe simflar
experiment with urethane, both this criterion and also the average number of
tumours per surviving mouse. Our results show that the initiating effect of
urethane persists in part for at least 24 weeks. There appears to be a loss of
effect, in thistime, ofthe order of 50 per cent. For reasonsgiven above weregard the evidence for a realfalling-offofthe effect with time as inconclusive.
SUMMARY.
1. The relative power of different doses of ethyl carbamate (urethane) to
initiate carcinogenesis in mouse skin have been studied. In all groups a standard
course of 18 weekly applications of 0-5 per cent croton oil were begun 3 weeks
after treatment with urethane, and the incidence of tumours recorded week by week.
2. The relation between dose and initiating effect of urethane over the dose
range 2-240 mg. does not differ significantly from simple direct proportionality.
3. Attempts were made to enhance the initiating effect of urethane by pro- longing its period of contact with the skin. Neither increasing the intervals676 F. J. C. ROE AND M. H. SALAMAN
betweenappHcations of urethane from 2 hours to 4 days, norchanging the solvent
from acetone to carbowax 300, which is viscous and non-volatile, had any signifi-
cant effect on tumour incidence.
4. A study was made of the persistence of the initiating effect of urethane in
mouse skin. Results showed that the effect persists for at least 24 weeks, though
with some apparent diminution. The evidence for an actual falling-off of the
effect with time is suggestive but not conclusive.
5. The significance of these findings is discussed in the light of those of other
workerswhostudiedtheinitiatingeffect ofsingleandrepeateddoses ofcarcinogenic
hydrocarbons.
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